A specialist journal devoted to melanoma, from tumour genetics and immunology to case reports and clinical studies of targeted and immune therapies.
Melanoma Research is published by Lippincott Williams & Wilkins, part of Wolters Kluwer, and is hosted on the Ovid journals platform. The journal page lists six issues a year under Editors-in-Chief F. J. Lejeune and W. J. Storkus and shows a mix of clinical and laboratory papers on melanoma: recent issue highlights include a case report of haemophagocytic lymphohistiocytosis and posterior reversible encephalopathy syndrome during BRAF/MEK inhibitor therapy after immune checkpoint blockade, and a study associating chemokine and chemokine receptor gene variants with multiple primary melanoma. NLM records the journal as starting in 1991 (print ISSN 0960-8931, electronic ISSN 1473-5636), published in London, and currently indexed in MEDLINE.
Shares Uveal melanoma, PubMed & Europe PMC, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.
Shares Uveal melanoma, Melanoma.